Literature DB >> 18836792

Involved field radiation therapy and donor lymphocyte infusion for relapsed or refractory non-Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation.

G Behre1, M Christopeit2, T Weber2.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18836792     DOI： 10.1007/s12185-008-0174-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  2 in total

1.  High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma.

Authors:  Adrian J C Bloor; Kirsty Thomson; Noha Chowdhry; Stephanie Verfuerth; Stuart J Ings; Ronjon Chakraverty; David C Linch; Anthony H Goldstone; Karl S Peggs; Stephen Mackinnon
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

2.  Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.

Authors:  Christoph Schmid; Myriam Labopin; Arnon Nagler; Martin Bornhäuser; Jürgen Finke; Athanasios Fassas; Liisa Volin; Günham Gürman; Johan Maertens; Pierre Bordigoni; Ernst Holler; Gerhard Ehninger; Emmanuelle Polge; Norbert-Claude Gorin; Hans-Jochem Kolb; Vanderson Rocha
Journal:  J Clin Oncol       Date:  2007-10-01       Impact factor: 44.544
  2 in total
  3 in total

1.  Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation.

Authors:  Ron Ram; Ted A Gooley; David G Maloney; Oliver W Press; John M Pagel; Stephen H Petersdorf; Andrei R Shustov; Mary E D Flowers; Paul O'Donnell; Brenda M Sandmaier; Rainer F Storb; Ajay K Gopal
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-12       Impact factor: 5.742

2.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  David L Porter; Edwin P Alyea; Joseph H Antin; Marcos DeLima; Eli Estey; J H Frederik Falkenburg; Nancy Hardy; Nicolaus Kroeger; Jose Leis; John Levine; David G Maloney; Karl Peggs; Jacob M Rowe; Alan S Wayne; Sergio Giralt; Michael R Bishop; Koen van Besien
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-10       Impact factor: 5.742

Review 3.  Trial Watch: Anticancer radioimmunotherapy.

Authors:  Erika Vacchelli; Ilio Vitale; Eric Tartour; Alexander Eggermont; Catherine Sautès-Fridman; Jérôme Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-07-03       Impact factor: 8.110
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.